49 related articles for article (PubMed ID: 28479075)
21. Use of the Papanicolaou test in women under 25 years of age in Southern Alberta.
Snodgrass R; Naugler C
J Obstet Gynaecol Can; 2014 Apr; 36(4):320-3. PubMed ID: 24798669
[TBL] [Abstract][Full Text] [Related]
22. [Cytological study of 191 women with invasive cancer of the uterine cervix in Brittany, France].
Lavoué V; Gautier C; Piette C; Porée P; Mesbah H; Foucher F; Vialard J; Levêque J
J Gynecol Obstet Biol Reprod (Paris); 2009 Sep; 38(5):396-403. PubMed ID: 19473783
[TBL] [Abstract][Full Text] [Related]
23. A membrane filter method for correlating colposcopic, histological, and cytological pictures: the application to nuclear DNA measurements.
Burn GP; Singer A; Spriggs AI
J Clin Pathol; 1974 Jul; 27(7):542-7. PubMed ID: 4138604
[TBL] [Abstract][Full Text] [Related]
24. Adherence to gynecological screening impacted by experienced orthodontic treatment in childhood.
Schott S; Heinzler J; Rippinger N; Bruckner T; Brucker J; Hoffmann J; Dornhöfer N; Dinkic C; Seitz S; Rom J; Sohn C; Schott TC
Arch Gynecol Obstet; 2019 Jan; 299(1):167-171. PubMed ID: 30374649
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Cytological Abnormalities in Papanicolaou Smears and Risk Factors for Cervical Cancer Among Women in Muscat, Oman.
Al Sekri E; Al Musalhi A; Al Abri K; Al Kindi H; Al Salmani AA
Sultan Qaboos Univ Med J; 2021 Nov; 21(4):598-603. PubMed ID: 34888080
[TBL] [Abstract][Full Text] [Related]
26. Factors of importance for the use of PAP-SMEAR in a Danish county without systematic screening.
Olesen F; Holm M
Scand J Prim Health Care; 1990 Jul; 8(2):69-73. PubMed ID: 2218156
[TBL] [Abstract][Full Text] [Related]
27. HIV status and positive Papanicolaou screening: identification of a high-risk population.
Provencher D; Valme B; Averette HE; Ganjei P; Donato D; Penalver M; Sevin BU
Gynecol Oncol; 1988 Sep; 31(1):184-90. PubMed ID: 3410346
[No Abstract] [Full Text] [Related]
28. High HPV prevalence and need for ancillary care.
Brown B
Braz J Infect Dis; 2015; 19(1):110. PubMed ID: 25523078
[No Abstract] [Full Text] [Related]
29. Attitude and behaviour correlates of cytological screening in women.
Hill DJ
Med J Aust; 1971 Aug; 2(7):375-7. PubMed ID: 5092895
[No Abstract] [Full Text] [Related]
30. Cytological Screening for Cancer of the Cervix.
Br Med J; 1963 Jun; 1(5346):1625-6. PubMed ID: 20789856
[No Abstract] [Full Text] [Related]
31. Cytological screening for cancer.
Wachtel E
Proc R Soc Med; 1976 Aug; 69(8):625. PubMed ID: 20919240
[No Abstract] [Full Text] [Related]
32. Pap smear accuracy for the diagnosis of cervical precancerous lesions.
Nkwabong E; Laure Bessi Badjan I; Sando Z
Trop Doct; 2019 Jan; 49(1):34-39. PubMed ID: 30222058
[TBL] [Abstract][Full Text] [Related]
33. Screening for Cervical Cancer.
Eun TJ; Perkins RB
Med Clin North Am; 2020 Nov; 104(6):1063-1078. PubMed ID: 33099451
[TBL] [Abstract][Full Text] [Related]
34. [Pap smear before 25 years old].
Rousselin A; Dion L; Racin A; Lavoué V; Levêque J; Nyangoh Timoh K
Gynecol Obstet Fertil Senol; 2017 May; 45(5):309-315. PubMed ID: 28479075
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
36. [Pap Smear after 65 years].
Enderle I; Le Baccon FA; Pinsard M; Joueidi Y; Lavoué V; Levêque J; Nyangoh Timoh K
Gynecol Obstet Fertil Senol; 2017 Sep; 45(9):478-485. PubMed ID: 28864050
[TBL] [Abstract][Full Text] [Related]
37. [Cervical Pap smear in an epidemiologically exposed population: ideas, facts and arguments].
Doris B; Boyer L; Lavoué V; Riou F; Henno S; Tas P; Sévène L; Levêque J
J Gynecol Obstet Biol Reprod (Paris); 2014 Jan; 43(1):26-34. PubMed ID: 24332738
[TBL] [Abstract][Full Text] [Related]
38. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
39. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
